Alterations in forearm vascular reactivity in patients with septic shock

Anaesthesia

Volumn 63, Issue 2, 2008, Pages 121-128

  Kienbaum, P ^a   Prante, C ^a   Lehmann, N ^b   Sander, A ^a   Jalowy, A ^a   Peters, J ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN 2 RECEPTOR; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; VASOCONSTRICTOR AGENT; VASOPRESSIN;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; FEMALE; FOREARM; FOREARM BLOOD FLOW; HUMAN; MALE; SCORING SYSTEM; SEDATION; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ADULT; AGED; ENDOTHELIUM, VASCULAR; FOREARM; HUMANS; MIDDLE AGED; PLETHYSMOGRAPHY; SHOCK, SEPTIC; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VASOPRESSINS;

EID: 38349077080     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.05286.x     Document Type: Article

References (29)

1. Parrillo JE. Pathogenetic mechanisms of septic shock. New England Journal of Medicine 1993 328 : 1471 7.
2. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. New England Journal of Medicine 2001 345 : 588 95.
3. Thiemermann C, Wu CC, Szabo C, Perretti M, Vane JR. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. British Journal of Pharmacology 1993 110 : 177 82.
4. Palsson J, Ricksten SE, Delle M, Lundin S. Changes in renal sympathetic nerve activity during experimental septic and endotoxin shock in conscious rats. Circulatory Shock 1988 24 : 133 41.
5. Bucher M, Ittner KP, Hobbhahn J, Taeger K, Kurtz A. Downregulation of angiotensin II Type 1 receptors during sepsis. Hypertension 2001 38 : 177 82.
6. Leinhardt DJ, Arnold J, Shipley KA, Mughal MM, Little RA, Irving MH. Plasma norepinephrine concentrations do not accurately reflect sympathetic nervous system activity in human sepsis. American Journal of Physiology 1993 265 : E284 8.
7. Annane D, Bellissant E, Sebille V, Lesieur O, Mathieu B, Raphael JC, et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. British Journal of Clinical Pharmacology 1998 46 : 589 97.
8. Donaldson LL, Myers AK. Effect of pharmacological agonists on contractile responses in aortic rings derived from endotoxaemic rats. Journal of Veterinary Pharmacology and Therapeutics 1996 5 : 389 96.
9. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002 96 : 576 82.
10. Guzman JA, Rosado AE, Kruse JA. Vasopressin vs. norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects. Journal of Applied Physiology 2003 95 : 803 9.
11. Whitney RJ. The measurement of volume changes in human limbs. Journal of Physiology 1953 121 : 1 27.
12. Joyner MJ, Dietz NM, Shepherd JT. From Belfast to Mayo and beyond: the use and future of plethysmography to study blood flow in human limbs. Journal of Applied Physiology 2001 91 : 2431 41.
13. Gomez-Jiminez J, Slgado A, Mourelle M, Martin MC, Segura RM, Peracaula R, et al. l-Arginine: Nitric oxide pathway in endotoxemia and human septic shock. Critical Care Medicine 1995 23 : 253 8.
14. Petros A, Lamb G, Leone A, Moncada S, Bennet D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovascular Research 1994 28 : 34 9.
15. Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock. Journal of Clinical Investigation 1997 100 : 723 35.
16. Pleiner J, Heere-Ress E, Langenberger H, Sieder AE, Bayerle-Eder M, Mittermayer F, et al. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arteriosclerosis, Thrombosis and Vascular Biology 2002 22 : 95 100.
17. Mittermayer F, Pleiner J, Schaller G, Zorn S, Namiranian K, Kapiotis S, et al. Tetrahydobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction. American Journal of Physiology 2005 289 : H1752 7.
18. Kubli S, Boegli Y, Ave AD, Liaudet L, Revelly JP, Golay S, et al. Endothelium-dependent vasodilation in the skin microcirculation of patients with septic shock. Shock 2003 19 : 274 80.
19. Boillot A, Massol J, Maupoil V, Grelier R, Capellier G, Berthelot A, et al. Alterations of myocardial and vascular adrenergic responses in Escherichia coli-induced septic shock in the rat. Critical Care Medicine 1996 24 : 1373 80.
20. Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions. Physiology Review 2005 85 : 1159 204.
21. Dong LW, Yang J, Tong LJ, Tang C, Liu MS. Transcriptional regulation of alpha-1-adrenoceptor gene in the rat liver during different phases of sepsis. Biochimica Biophysica Acta 1999 1453 : 207 15.
22. Schaller MD, Waeber B, Nussberger J, Brunner HR. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. American Journal of Physiology 1985 249 : H1086 92.
23. Ohtani R, Ohashi Y, Muranaga K, Itoh N, Okamoto H. Changes in activity of the renin-angiotensin system of the rat by induction of acute inflammation. Life Sciences 1989 44 : 237 41.
24. Tarpey SB, Bennett T, Randall MD, Gardiner SM. Differential effects of endotoxemia on pressor and vasoconstrictor actions of angiotensin II and arginin vasopressin in conscious rats. British Journal of Pharmacology 1998 123 : 1367 74.
25. Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, D'Alessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997 95 : 1122 5.
26. Sharshar T, Carlier R, Blanchard A, Fydy A, Gray F, Paillard M, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Critical Care Medicine 2002 30 : 497 500.
27. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Critical Care Medicine 2001 29 : 487 93.
28. Malay MB, Ashton RC Jr., Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. Journal of Trauma 1999 47 : 699 703.
29. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Medicine 2001 27 : 1416 21.